RxDoctor Payments Data

Eric Paulson

Geriatric Medicine · Red Oak, IANPI 1508863341

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,172 and has fallen 84.1% since, to $186 in 2021.

$1,525in general payments, 2019–2025

Across 121 payments — averaging $12.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$225
  • Lilly USA, LLC$216
  • Pfizer$215
  • Amgen$148
  • Boehringer Ingelheim$140
  • Astellas Pharma US Inc$113
  • plus $468 from 13 others

What the payments were for

  • Food & beverage$1,51799%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few geriatric medicine providers in Iowato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium12$186
Sertraline Hcl12$121

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Red Oak

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →